Zai Lab Ltd
ZLAB
27 insider filings · Latest: May 26, 2026
Common Stock Transactions
| Txn Date | Accepted | Insider | Type | Shares | Avg Price | Value | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|---|
| Mar 11, 2026 | Mar 11 7:21 PM | Du Ying | Proposed Sale | 1,067 | $19.08 | $20.4K | — | View → |
| Mar 9, 2026 | Mar 10 8:08 PM | Ying DuDirector, Chairperson & CEO | Sale | 50,000 | $19.03 | $951.5K | 964,161(D) | View → |
| Mar 6, 2026 | Mar 10 8:08 PM | Ying DuDirector, Chairperson & CEO | Sale | 50,000 | $19.42 | $970.9K | 964,161(D) | View → |
| Mar 9, 2026 | Mar 9 6:12 PM | Du Ying | Proposed Sale | 50,000 | $19.21 | $960.5K | — | View → |
| Mar 5, 2026 | Mar 6 9:26 PM | Frazor Titus Edmondson IIIChief Legal Officer | Sale | 15,569 | $19.06 | $296.7K | 3,517(D) | View → |
| Mar 5, 2026 | Mar 6 9:25 PM | Ying DuDirector, Chairperson & CEO | Sale | 50,000 | $19.22 | $961.1K | 964,161(D) | View → |
| Mar 4, 2026 | Mar 6 9:25 PM | Ying DuDirector, Chairperson & CEO | Sale | 50,000 | $19.16 | $958.2K | 964,161(D) | View → |
| Mar 6, 2026 | Mar 6 3:57 PM | Du Ying | Proposed Sale | 50,000 | $19.18 | $959.0K | — | View → |
| Mar 3, 2026 | Mar 5 9:07 PM | Rafael AmadoPresident, Head of Global Oncology Research and Development | Sale | 10,000 | $17.38 | $173.8K | 42,391(D) | View → |
| Mar 5, 2026 | Mar 5 6:20 PM | Edmondson Frazor Titus III | Proposed Sale | 15,569 | $19.06 | $296.7K | — | View → |
| Mar 5, 2026 | Mar 5 6:12 PM | Du Ying | Proposed Sale | 50,000 | $19.06 | $953.0K | — | View → |
| Mar 4, 2026 | Mar 4 4:21 PM | Du Ying | Proposed Sale | 50,000 | $18.28 | $914.0K | — | View → |
| Mar 3, 2026 | Mar 3 5:38 PM | Amado Rafael | Proposed Sale | 10,000 | $17.38 | $173.8K | — | View → |
| Dec 31, 2025 | Dec 31 8:29 PM | Amado Rafael | Proposed Sale | 10,787 | $17.43 | $188.0K | — | View → |
| Dec 16, 2025 | Dec 16 3:47 PM | Edmondson Frazor Titus III | Proposed Sale | 8,651 | $17.14 | $148.3K | — | View → |
| Nov 21, 2025 | Nov 21 2:43 PM | Edmondson Frazor Titus III | Proposed Sale | 14,328 | $19.78 | $283.4K | — | View → |
| Nov 3, 2025 | Nov 3 8:31 PM | Chen Yajing | Proposed Sale | 240 | $26.83 | $6.4K | — | View → |
| Oct 2, 2025 | Oct 2 7:36 PM | Chen Yajing | Proposed Sale | 456 | $34.25 | $15.6K | — | View → |
| Aug 18, 2025 | Aug 18 7:15 PM | Edmondson Frazor Titus III | Proposed Sale | 1,883 | $36.24 | $68.2K | — | View → |
| Aug 18, 2025 | Aug 18 7:14 PM | Smiley Joshua L | Proposed Sale | 6,641 | $36.24 | $240.6K | — | View → |
Stock Options & Derivatives
| Txn Date | Accepted | Insider | Type | Shares | Exercise Price | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|
| May 11, 2026 | Jun 8 8:29 PM | Yizhe WangOperating Partner | Grant/Award | 196,107 | $20.32 | 59,288(D) | View → |
| May 19, 2026 | May 21 8:19 PM | Ying DuDirector, Chairperson & CEO | Option Exercise | 261,092 | $1.74 | 0(D) | View → |
| May 18, 2026 | May 19 8:18 PM | Ying DuDirector, Chairperson & CEO | Option Exercise | 50,000 | $1.74 | 261,092(D) | View → |
| May 15, 2026 | May 19 8:18 PM | Ying DuDirector, Chairperson & CEO | Option Exercise | 50,000 | $1.74 | 311,092(D) | View → |
| May 14, 2026 | May 15 8:45 PM | Ying DuDirector, Chairperson & CEO | Option Exercise | 50,000 | $1.74 | 361,092(D) | View → |
| May 13, 2026 | May 15 8:45 PM | Ying DuDirector, Chairperson & CEO | Option Exercise | 50,000 | $1.74 | 411,092(D) | View → |
| Apr 2, 2026 | Apr 3 9:59 PM | Joshua L SmileyPresident and Chief Operating Officer | Option Exercise | 7,145 | — | 7,145(D) | View → |
| Apr 1, 2026 | Apr 3 9:59 PM | Joshua L SmileyPresident and Chief Operating Officer | Option Exercise | 32,062 | — | 64,125(D) | View → |
| Mar 4, 2026 | Apr 3 9:59 PM | Joshua L SmileyPresident and Chief Operating Officer | Grant/Award | 17,887 | — | 17,887(D) | View → |
| Apr 2, 2026 | Apr 3 9:58 PM | Frazor Titus Edmondson IIIChief Legal Officer | Option Exercise | 5,031 | — | 5,032(D) | View → |
| Apr 1, 2026 | Apr 3 9:58 PM | Frazor Titus Edmondson IIIChief Legal Officer | Option Exercise | 17,259 | — | 27,516(D) | View → |
| Mar 4, 2026 | Apr 3 9:58 PM | Frazor Titus Edmondson IIIChief Legal Officer | Grant/Award | 11,924 | — | 11,924(D) | View → |
| Apr 2, 2026 | Apr 3 9:58 PM | Ying DuDirector, Chairperson & CEO | Option Exercise | 6,750 | — | 13,500(D) | View → |
| Apr 1, 2026 | Apr 3 9:58 PM | Ying DuDirector, Chairperson & CEO | Option Exercise | 14,200 | — | 0(D) | View → |
| Mar 4, 2026 | Apr 3 9:58 PM | Ying DuDirector, Chairperson & CEO | Grant/Award | 25,579 | — | 25,579(D) | View → |
| Apr 2, 2026 | Apr 3 9:57 PM | Yajing ChenChief Financial Officer | Option Exercise | 2,500 | — | 2,500(D) | View → |
| Apr 1, 2026 | Apr 3 9:57 PM | Yajing ChenChief Financial Officer | Option Exercise | 15,258 | — | 27,516(D) | View → |
| Mar 4, 2026 | Apr 3 9:57 PM | Yajing ChenChief Financial Officer | Grant/Award | 11,924 | — | 11,924(D) | View → |
| Apr 2, 2026 | Apr 3 9:57 PM | Rafael AmadoPresident, Head of Global Oncology Research and Development | Option Exercise | 5,391 | — | 5,391(D) | View → |
| Apr 1, 2026 | Apr 3 9:57 PM | Rafael AmadoPresident, Head of Global Oncology Research and Development | Option Exercise | 19,523 | — | 39,046(D) | View → |
Page 1 of 2
Next →